戒烟和尼古丁成瘾预防产品市场报告：到 2030 年的趋势、预测和竞争分析

戒烟和尼古丁成瘾预防产品的趋势和预测

2024年至2030年，全球戒烟和尼古丁成瘾预防产品市场预计将以16.0%的复合年增长率成长。该市场的主要驱动力是人们对吸烟带来的健康风险和戒烟益处的认识不断提高，以及烟盒上图形警告和公共场所禁烟等法规的加强。全球戒烟和尼古丁成瘾预防产品市场前景广阔，医院药局、线上供应商、药局和零售药局都有未来性。

戒烟和尼古丁成瘾产品市场洞察

Lucintel 预测，由于对尼古丁替代疗法产品的需求不断增长，口香糖仍将是最大的细分市场。

在这个市场中，由于快速数位化、易于购买和快速交付产品，线上提供者预计将呈现最高成长。

由于该地区政府倡议不断增加、医疗基础设施发达以及电子烟普及较高，北美在预测期内可能仍将是最大的地区。

本报告回答了 11 个关键问题：

• Q.1. 细分市场中最有前途和高成长的机会是什么？
• Q.2.哪个细分市场将以更快的速度成长？为什么？
• Q.3.您认为哪些地区未来会出现更快的成长？为什么？
• Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和业务风险是什么？
• Q.5. 这个市场的商业风险和竞争威胁是什么？
• Q.6.这个市场有哪些新趋势？为什么？
• Q.7.市场客户需求有何改变？
• Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
• Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
• Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
• Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球戒烟与尼古丁成瘾产品市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 戒烟和尼古丁成瘾预防产品的全球市场趋势（2018-2023）和预测（2024-2030）
• 按型态分類的全球戒烟和尼古丁成瘾预防产品市场
  • 胶
  • 吸入器
  • 药片
  • 其他的
• 全球戒烟和尼古丁成瘾预防产品市场（按产品）
  • 尼古丁替代疗法产品
  • 药物治疗
  • 电子烟
• 按配销通路分類的全球戒烟和尼古丁成瘾预防产品市场
  • 医院药房
  • 线上提供者
  • 药局/零售药房

第四章 2018-2030年区域市场趋势及预测分析

• 按地区分類的全球戒烟和尼古丁成瘾预防产品市场
• 北美戒烟及尼古丁成瘾预防产品市场
• 欧洲戒烟和尼古丁成瘾预防产品市场
• 亚太戒烟和尼古丁成瘾预防产品市场
• 其他地区的戒烟及尼古丁成瘾产品市场

第五章竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球戒烟和尼古丁成瘾产品市场的成长机会（按型态）
  • 全球戒烟和尼古丁成瘾产品市场的成长机会（按产品）
  • 按配销通路的全球戒烟和尼古丁成瘾产品市场的成长机会
  • 按地区分類的全球戒烟和尼古丁成瘾预防产品市场的成长机会
• 全球戒烟及尼古丁成瘾预防产品市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球戒烟和尼古丁成瘾预防产品市场的容量
  • 全球戒烟和尼古丁成瘾预防产品市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Pfizer
• Imperial Brands
• Njoy Company
• GlaxoSmithKline
• British American Tobacco
• Perrigo Company
• Johnson and Johnson
• Rusan Pharma
• Dr. Reddy's Laboratories
• 22nd Century

Smoking Cessation and Nicotine De-Addiction Products Trends and Forecast

The future of the global smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets. The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030. The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

A more than 150-page report is developed to help in your business decisions.

Smoking Cessation and Nicotine De-Addiction Products by Segment

The study includes a forecast for the global smoking cessation and nicotine de-addiction products by form, product, distribution channel, and region.

Smoking Cessation and Nicotine De-Addiction Products Market by Form [Shipment Analysis by Value from 2018 to 2030]:

• Gum
• Inhaler
• Tablet
• Others

Smoking Cessation and Nicotine De-Addiction Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Nicotine Replacement Therapy Products
• Drug Therapy
• E-Cigarettes

Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Online Provider
• Drug Stores and Retail Pharmacies

Smoking Cessation and Nicotine De-Addiction Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Smoking Cessation and Nicotine De-Addiction Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies smoking cessation and nicotine de-addiction products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smoking cessation and nicotine de-addiction products companies profiled in this report include-

• Pfizer
• Imperial Brands
• Njoy Company
• Glaxosmithkline
• British American Tobacco
• Perrigo Company
• Johnson And Johnson
• Rusan Pharma
• Dr. Reddy'S Laboratories
• 22nd Century

Smoking Cessation and Nicotine De-Addiction Products Market Insights

Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.

Within this market, online provider is expected to witness highest growth due to rapid digitalization, ease of purchase, and quicker delivery of products.

North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Features of the Global Smoking Cessation and Nicotine De-Addiction Products Market

Market Size Estimates: Smoking cessation and nicotine de-addiction products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smoking cessation and nicotine de-addiction products market size by form, product, distribution channel, and region in terms of value ($B).

Regional Analysis: Smoking cessation and nicotine de-addiction products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different forms, products, distribution channels, and regions for the smoking cessation and nicotine de-addiction products market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smoking cessation and nicotine de-addiction products market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for smoking cessation and nicotine de-addiction products market?

Answer: The global smoking cessation and nicotine de-addiction products market is expected to grow with a CAGR of 16.0% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the smoking cessation and nicotine de-addiction products market?

Answer: The major drivers for this market are increased awareness of the health risks associated with smoking and the benefits of quitting and increasing stringent regulations like graphic warnings on cigarette packs and smoking bans in public places.

Q3. What are the major segments for smoking cessation and nicotine de-addiction products market?

Answer: The future of the smoking cessation and nicotine de-addiction products market looks promising with opportunities in the hospital pharmacies, online provider, drug stores and retail pharmacies markets.

Q4. Who are the key smoking cessation and nicotine de-addiction products market companies?

Answer: Some of the key smoking cessation and nicotine de-addiction products companies are as follows:

• Pfizer
• Imperial Brands
• Njoy Company
• Glaxosmithkline
• British American Tobacco
• Perrigo Company
• Johnson And Johnson
• Rusan Pharma
• Dr. Reddy'S Laboratories
• 22nd Century

Q5. Which smoking cessation and nicotine de-addiction products market segment will be the largest in future?

Answer: Lucintel forecasts that gum will remain the largest segment due to growing demand for the nicotine replacement therapy products.

Q6. In smoking cessation and nicotine de-addiction products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing government initiatives, presence of well-developed healthcare infrastructure, and high adoption of e-cigarettes in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the smoking cessation and nicotine de-addiction products market by form (gum, inhaler, tablet, and others), product (nicotine replacement therapy products, drug therapy, and e-cigarettes), distribution channel (hospital pharmacies, online provider, and drug stores and retail pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Smoking Cessation and Nicotine De-Addiction Products Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Smoking Cessation and Nicotine De-Addiction Products Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Smoking Cessation and Nicotine De-Addiction Products Market by Form
  • 3.3.1: Gum
  • 3.3.2: Inhaler
  • 3.3.3: Tablet
  • 3.3.4: Others
• 3.4: Global Smoking Cessation and Nicotine De-Addiction Products Market by Product
  • 3.4.1: Nicotine Replacement Therapy Products
  • 3.4.2: Drug Therapy
  • 3.4.3: E-cigarettes
• 3.5: Global Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel
  • 3.5.1: Hospital Pharmacies
  • 3.5.2: Online Provider
  • 3.5.3: Drug stores and Retail Pharmacies

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Smoking Cessation and Nicotine De-Addiction Products Market by Region
• 4.2: North American Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.2.2: North American Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
• 4.3: European Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.3.1: European Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
  • 4.3.2: European Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
• 4.4: APAC Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.4.1: APAC Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
  • 4.4.2: APAC Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies
• 4.5: ROW Smoking Cessation and Nicotine De-Addiction Products Market
  • 4.5.1: ROW Smoking Cessation and Nicotine De-Addiction Products Market by Form: Gum, Inhaler, Tablet, and Others
  • 4.5.2: ROW Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel: Hospital Pharmacies, Online Provider, and Drug stores and Retail Pharmacies

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Form
  • 6.1.2: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Product
  • 6.1.3: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Smoking Cessation and Nicotine De-Addiction Products Market by Region
• 6.2: Emerging Trends in the Global Smoking Cessation and Nicotine De-Addiction Products Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Smoking Cessation and Nicotine De-Addiction Products Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Smoking Cessation and Nicotine De-Addiction Products Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer
• 7.2: Imperial Brands
• 7.3: Njoy Company
• 7.4: GlaxoSmithKline
• 7.5: British American Tobacco
• 7.6: Perrigo Company
• 7.7: Johnson and Johnson
• 7.8: Rusan Pharma
• 7.9: Dr. Reddy's Laboratories
• 7.10: 22nd Century